Related Experiment Video
Updated: Sep 26, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Catheter-Directed Thrombectomy: An Alternative in Massive Pulmonary Embolism
Andres Cordova Sanchez1, Mostafa Vasigh2, Oluwateniola Olatunde2
1Department of Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
Massive pulmonary embolism (PE) is a life-threatening condition. Catheter-directed thrombectomy, a new technique, was successfully used to treat a patient with massive PE, showing promise for this critical condition.
Area of Science:
- Cardiology
- Interventional Pulmonology
- Vascular Surgery
Background:
- Massive pulmonary embolism (PE) poses a significant risk to life.
- Thrombolysis remains the primary treatment for massive PE.
- Emerging catheter-directed thrombectomy techniques offer potential for lower complications and mortality.
Observation:
- This case report details the treatment of a patient diagnosed with massive PE.
- The patient underwent a catheter-directed thrombectomy procedure.
- This intervention was chosen despite prior studies focusing on submassive PE.
Findings:
- Catheter-directed thrombectomy was successfully performed in a patient with massive PE.
- The procedure demonstrated a viable alternative treatment option.
- This approach appears to be effective in managing acute, massive PE.
Implications:
- Catheter-directed thrombectomy may be a safe and effective treatment for massive PE.
- Further research is warranted to establish its role in clinical practice.
- This case expands the potential applications of minimally invasive thrombectomy techniques.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

